Ekso Bionics Inc. (EKSO) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Ekso Bionics Inc. (EKSO)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.69

-0.02 (-3.10%)

At close: Jan 14, 2025, 3:59 PM

0.69

-0.72%

Pre-market Jan 15, 2025, 06:57 AM EST

undefined% (undefined)

Bid	0.69
Market Cap	15.29M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.64
PE Ratio (ttm)	-1.09
Forward PE	n/a
Analyst	Buy

Ask	0.71
Volume	640,126
Avg. Volume (20D)	986,000
Open	0.74
Previous Close	0.71
Day's Range	0.67 - 0.74
52-Week Range	0.50 - 2.50
Beta	undefined

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices t...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Jan 17, 2014

Employees 70

Stock Exchange NASDAQ

Ticker Symbol EKSO

Website https://www.eksobionics.com

Analyst Forecast

According to 2 analyst ratings, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 691.37% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Ekso Bionics Inc. is scheduled to release its earnings on Mar 3, 2025, during market hours.
Analysts project revenue of $5.30M, reflecting a 9.35% YoY growth and earnings per share of -0.08, making a -63.64% decrease YoY.

Why Price Moved

2 months ago · Source

-15.03%

Ekso Bionics shares are trading lower after Lake S... Unlock content with Pro Subscription

5 months ago · Source

-28.86%

Esko Bionics Holdings shares are trading lower after the company reported worse-than-expected Q2 sales results.

News

2 months ago · zacks.com

Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.24 per share a year ago.

2 months ago · seekingalpha.com

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome...